Avant Genomics Holding

Avant Genomics is a Charlottesville, Virginia biotechnology company developing a first-of-its-kind platform that automates liquid biopsy sample preparation for blood-based cancer detection and therapeutic monitoring. The company holds exclusive IP developed at the University of Virginia and secured over $3 million in funding in May 2026 to accelerate its automated platform.